Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Nivolumab 22Specimen Handling 17pembrolizumab 13cabozantinib 13Magnetic Resonance Spectroscopy 13belzutifan 12Ipilimumab 12lenvatinib 7Axitinib 7CTLA-4 Antigen 6Biopsy 6atezolizumab 4Sunitinib 4tivozanib 3Surveys and Questionnaires 3Immunoglobulin G 3Everolimus 3Disulfides 3relatlimab 2pazopanib 2palbociclib 2aldesleukin 2Watchful Waiting 2Standard of Care 2Radiosurgery 2Practice Guidelines as Topic 2Nephrectomy 2Bevacizumab 2zimberelimab 1ulixertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Kidney Transplantation × 30 days × Clear all
NCT05725421 2026-05-28

Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy

Case Comprehensive Cancer Center

Phase NA Withdrawn
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡